149 related articles for article (PubMed ID: 28417967)
1. Nomograms for predicting the prognostic value of serological tumor biomarkers in colorectal cancer patients after radical resection.
Li Q; Dai W; Li Y; Xu Y; Li X; Cai S
Sci Rep; 2017 Apr; 7():46345. PubMed ID: 28417967
[TBL] [Abstract][Full Text] [Related]
2. Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection.
Li Y; Jia H; Yu W; Xu Y; Li X; Li Q; Cai S
Int J Cancer; 2016 Jul; 139(1):220-31. PubMed ID: 26933932
[TBL] [Abstract][Full Text] [Related]
3. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of lymph node metastasis in patients with T1-stage colorectal cancer from multiple centers in China.
Sun ZQ; Ma S; Zhou QB; Yang SX; Chang Y; Zeng XY; Ren WG; Han FH; Xie X; Zeng FY; Sun XT; Wang GX; Li Z; Zhang ZY; Song JM; Liu JB; Yuan WT
World J Gastroenterol; 2017 Dec; 23(48):8582-8590. PubMed ID: 29358866
[TBL] [Abstract][Full Text] [Related]
5. A nomogram based on pretreatment levels of serum bilirubin and total bile acid levels predicts survival in colorectal cancer patients.
Cao Y; Deng S; Yan L; Gu J; Yang J; Yang M; Liu L; Cai K
BMC Cancer; 2021 Jan; 21(1):85. PubMed ID: 33478423
[TBL] [Abstract][Full Text] [Related]
6. CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242.
Björkman K; Mustonen H; Kaprio T; Kekki H; Pettersson K; Haglund C; Böckelman C
Tumour Biol; 2021; 43(1):57-70. PubMed ID: 33935125
[TBL] [Abstract][Full Text] [Related]
7. Nomograms for predicting the prognosis of stage IV colorectal cancer after curative resection: a multicenter retrospective study.
Kawai K; Ishihara S; Yamaguchi H; Sunami E; Kitayama J; Miyata H; Sugihara K; Watanabe T
Eur J Surg Oncol; 2015 Apr; 41(4):457-65. PubMed ID: 25697470
[TBL] [Abstract][Full Text] [Related]
8. Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma.
Xu HX; Liu L; Xiang JF; Wang WQ; Qi ZH; Wu CT; Liu C; Long J; Xu J; Ni QX; Yu XJ
Surgery; 2017 Feb; 161(2):373-384. PubMed ID: 27838102
[TBL] [Abstract][Full Text] [Related]
9. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer.
Yang XQ; Chen C; Wang FB; Peng CW; Li Y
Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of nomograms for predicting survival in patients with non-metastatic colorectal cancer.
Jiang H; Tang E; Xu D; Chen Y; Zhang Y; Tang M; Xiao Y; Zhang Z; Deng X; Li H; Lin M
Oncotarget; 2017 May; 8(18):29857-29864. PubMed ID: 28415740
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of preoperative serum CA724 for CEA-normal colorectal cancer patients.
Kuang J; Gong Y; Xie H; Yan L; Huang S; Gao F; Tang S; Gan J
PeerJ; 2020; 8():e8936. PubMed ID: 32328348
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of nomograms for prediction of overall survival and cancer-specific survival of patients with Stage IV colorectal cancer.
Zhang J; Gong Z; Gong Y; Guo W
Jpn J Clin Oncol; 2019 May; 49(5):438-446. PubMed ID: 30924498
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients.
Ying HQ; Deng QW; He BS; Pan YQ; Wang F; Sun HL; Chen J; Liu X; Wang SK
Med Oncol; 2014 Dec; 31(12):305. PubMed ID: 25355641
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic Value of Preoperative Serum CEA and CA19-9 Values in Stage I-III Colorectal Cancer.
Wang RF; Song BR; Peng JJ; Cai GX; Liu FQ; Wang MH; Cai SJ; Ye X
Hepatogastroenterology; 2014 Jun; 61(132):994-9. PubMed ID: 26158155
[TBL] [Abstract][Full Text] [Related]
15. Intensive risk-adjusted follow-up with the CEA, TPA, CA19.9, and CA72.4 tumor marker panel and abdominal ultrasonography to diagnose operable colorectal cancer recurrences: effect on survival.
Nicolini A; Ferrari P; Duffy MJ; Antonelli A; Rossi G; Metelli MR; Fulceri F; Anselmi L; Conte M; Berti P; Miccoli P
Arch Surg; 2010 Dec; 145(12):1177-83. PubMed ID: 21173292
[TBL] [Abstract][Full Text] [Related]
16. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer.
Chan JC; Chan DL; Diakos CI; Engel A; Pavlakis N; Gill A; Clarke SJ
Ann Surg; 2017 Mar; 265(3):539-546. PubMed ID: 27070934
[TBL] [Abstract][Full Text] [Related]
17. Survival nomograms for stage III colorectal cancer.
Li C; Pei Q; Zhu H; Tan F; Zhou Z; Zhou Y; Li Y; Pei H
Medicine (Baltimore); 2018 Dec; 97(49):e13239. PubMed ID: 30544384
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum homocysteine levels associated with poor recurrence-free and overall survival in patients with colorectal cancer.
Xie H; Wei L; Wang Q; Tang S; Gan J
Sci Rep; 2024 May; 14(1):10057. PubMed ID: 38698172
[TBL] [Abstract][Full Text] [Related]
19. Preoperative carcinoembryonic antigen and prognosis of colorectal cancer. An independent prognostic factor still reliable.
Li Destri G; Rubino AS; Latino R; Giannone F; Lanteri R; Scilletta B; Di Cataldo A
Int Surg; 2015 Apr; 100(4):617-25. PubMed ID: 25875542
[TBL] [Abstract][Full Text] [Related]
20. Nomograms to predict survival after colorectal cancer resection without preoperative therapy.
Zhang ZY; Luo QF; Yin XW; Dai ZL; Basnet S; Ge HY
BMC Cancer; 2016 Aug; 16(1):658. PubMed ID: 27553083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
